Literature DB >> 9183129

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

R J Schachar1, R Tannock, C Cunningham, P V Corkum.   

Abstract

OBJECTIVE: To determine the behavioral, situational, and temporal effects of 4 months of methylphenidate (MPH) treatment for attention-deficit hyperactivity disorder (ADHD).
METHOD: Ninety-one children with ADHD were randomly assigned to receive either MPH (titrated to a target dose of 0.7 mg/kg twice a day) or a placebo. Treatment effects were investigated with measures sensitive to various behaviors (core and associated symptoms), situations (home and school), time periods (morning and afternoon, after reaching the target dose, and after 4 months of treatment), and side effects.
RESULTS: MPH treatment improved symptoms of ADHD and oppositional behavior at school, both in the morning and afternoon, but not at home. Side effects (increase in physiological and effective symptoms, lack of weight gain) were significantly more frequent with MPH than with placebo treatment. Benefit was evident after titration, but the onset of some side effects was delayed. Side effects were reported by parents but not by teachers.
CONCLUSIONS: Positive effects of MPH on behavior are evident in the classroom, but with MPH given twice daily, parents do not report that MPH improves behavior at home. Greater impact on home behavior may require three times daily MPH and combined treatments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183129     DOI: 10.1097/00004583-199706000-00011

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  37 in total

Review 1.  Toward a transactional conceptualization of oppositional defiant disorder: implications for assessment and treatment.

Authors:  R W Greene; A E Doyle
Journal:  Clin Child Fam Psychol Rev       Date:  1999-09

Review 2.  Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Authors:  Morris Zwi; Hannah Jones; Camilla Thorgaard; Ann York; Jane A Dennis
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 3.  Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder: A Meta-analysis.

Authors:  Cellina Ching; Guy D Eslick; Alison S Poulton
Journal:  JAMA Pediatr       Date:  2019-07-01       Impact factor: 16.193

4.  The importance of parental attributions in families of children with attention-deficit/hyperactivity and disruptive behavior disorders.

Authors:  Charlotte Johnston; Jeneva L Ohan
Journal:  Clin Child Fam Psychol Rev       Date:  2005-09

5.  The use of stimulant medication in the treatment of attention deficit hyperactivity disorder.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-12       Impact factor: 2.253

6.  Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea.

Authors:  Bung-Nyun Kim; Ye-Ni Kim; Un-Sun Cheong; Jae-Won Kim; Jun-Won Hwang; Min-Sup Shin; Soo-Churl Cho
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

Review 7.  Review and comparison of the long acting methylphenidate preparations.

Authors:  Feng Liu; Rafael Muniz; Haruka Minami; Raul R Silva
Journal:  Psychiatr Q       Date:  2005

8.  Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions.

Authors:  Sarah V Spencer; Larry W Hawk; Jerry B Richards; Keri Shiels; William E Pelham; James G Waxmonsky
Journal:  J Abnorm Child Psychol       Date:  2009-08

Review 9.  Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

Authors:  Lily Hechtman; Brian Greenfield
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 10.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.